Sodium channel protein and T-type calcium channel protein (NaV (for sodium channel protein), CaV3 (for T-type calcium channel protein))

Sodium channels (NaV) and T-type calcium channels (CaV3) are distinct families of voltage-gated ion channel proteins critical for electrical signaling in neurons, muscle, and other excitable tissues. Sodium channels initiate and propagate action potentials, while T-type calcium channels enable rhythmic firing, pacemaking, and low-threshold calcium entry, particularly in cardiac and thalamic physiology. Both play major roles in health and disease: sodium channels are primary targets for anti-epileptic, local anesthetic, and antiarrhythmic drugs, while T-type calcium channels are targets for therapies in epilepsy, pain, and rhythm disorders. Despite overlapping roles in excitability, they are genetically, structurally, and pharmacologically distinct[1][2][3][4][5]. Note: For structured data or drug development, these two channels should be considered separately due to their distinct molecular identities and roles.

Other names

Sodium channel protein (NaV)Voltage-gated sodium channelT-type calcium channel protein (CaV3)Voltage-gated T-type calcium channel

Blockade of sodium ion conductance to inhibit action potential initiation and propagation (sodium channel blockers); Blockade of calcium ion entry to suppress pacemaker activity and reduce neurotransmitter/hormone release (T-type calcium channel blockers); Modulation of neuronal excitability and reduction of abnormal firing